Britannica
Sources used in this answer
Why is delivering a therapeutic gene into the correct human cells difficult?
Created from Britannica articles
using AI.
AI can make mistakes, so verify using Britannica articles.
genetic engineering
The generation of vaccines relies heavily on techniques in genetic engineering.
Delivering a therapeutic gene into the correct human cells is a complex challenge in gene therapy primarily because current delivery systems, often referred to as viral vectors, frequently fail to reach the intended target cells or the transferred genes fail to express themselves within those cells.1
Several factors contribute to these difficulties:
- Delivery Failures: Vectors may not successfully locate or enter the specific cells required for treatment.1
- Expression Issues: Even when a gene reaches a cell, it may not be properly expressed, meaning the cell does not produce the necessary therapeutic protein.1
- Immune Response: Although viral vectors are modified to be non-replicating, patients can still experience an adverse immune response to the delivery vehicle itself.1
- Integration Risks: If a gene integrates into the host genome, it may do so at a site that disrupts other functional genes, potentially causing new mutations or health complications, such as leukemia-like illnesses observed in some clinical trials.1
Researchers are currently investigating nanotechnology and nanoparticles to improve the precision and safety of these delivery systems.1